Subsequently, the tumor organoids were treated with anti‐PD‐1 and anti‐PD‐L1 agents, and the mRNA expression levels of crucial markers (granzyme B, perforin 1, and IFN‐γ) associated with tumor‐infiltrating T cell proliferation and activation were meticulously assessed. The gene discussed is PDCD1; the disease is neoplasm.